Does Tricare Cover Mounjaro? Insurance Guide 2026

Tricare, the healthcare program for uniformed service members, retirees, and their families, has evolved its coverage policies in recent years to address the growing demand for innovative treatments like Mounjaro. As of 2026, Mounjaro—a dual-action GLP-1 and GIP receptor agonist—has gained significant attention for its efficacy in managing type 2 diabetes and promoting weight loss. However, navigating Tricare’s coverage for Mounjaro can be complex, as it depends on medical necessity, prior authorization, and the specific condition being treated. This guide provides an evidence-based breakdown of Tricare’s policies on Mounjaro, including eligibility, costs, and steps to secure coverage.

Does Tricare Cover Mounjaro for Diabetes?

Tricare does cover Mounjaro for the treatment of type 2 diabetes under specific conditions. As a GLP-1 and GIP receptor agonist, Mounjaro (tirzepatide) has demonstrated superior glycemic control compared to other diabetes medications, such as semaglutide (Ozempic) and dulaglutide (Trulicity), in clinical trials like the SURPASS program. Tricare aligns with the American Diabetes Association (ADA) and the Department of Defense’s (DoD) clinical practice guidelines, which recommend GLP-1 receptor agonists as second-line therapy for patients who do not achieve target HbA1c levels with metformin alone.

To qualify for coverage, patients must meet the following criteria:

1. A confirmed diagnosis of type 2 diabetes.
2. Inadequate glycemic control (HbA1c ≥ 7.0%) despite lifestyle modifications and metformin therapy.
3. A documented intolerance or contraindication to other preferred diabetes medications, such as SGLT2 inhibitors (e.g., empagliflozin).

Tricare may also require prior authorization to ensure Mounjaro is medically necessary. Providers must submit evidence of failed alternative treatments and justify why Mounjaro is the most appropriate option. Without prior authorization, Tricare may deny coverage, leaving patients responsible for the full cost of Mounjaro, which can exceed $1,000 per month.

Does Tricare Cover Mounjaro for Weight Loss?

As of 2026, Tricare does not routinely cover Mounjaro for weight loss alone, as it is not FDA-approved solely for obesity treatment. However, Mounjaro received FDA approval in 2023 for chronic weight management in adults with obesity (BMI ≥ 30) or overweight (BMI ≥ 27) with at least one weight-related comorbidity (e.g., hypertension, dyslipidemia). Despite this approval, Tricare’s coverage policies have not fully aligned with this indication, primarily due to cost considerations and the DoD’s preference for lifestyle interventions as first-line therapy.

Tricare may approve Mounjaro for weight loss in exceptional cases, such as:

1. Patients with a BMI ≥ 40 (class III obesity) who have failed structured weight-loss programs (e.g., Tricare’s MOVE! program).
2. Individuals with obesity-related comorbidities (e.g., type 2 diabetes, sleep apnea) where weight loss is deemed medically necessary to improve health outcomes.
3. Documentation of failed trials with other weight-loss medications, such as phentermine or orlistat.

Patients seeking Mounjaro for weight loss must work closely with their provider to submit a prior authorization request, including evidence of medical necessity. Without this, Tricare will likely deny coverage, and patients may need to explore alternative options or pay out-of-pocket.

How Much Does Mounjaro Cost With Tricare?

The cost of Mounjaro with Tricare depends on several factors, including the patient’s specific Tricare plan (e.g., Prime, Select, or For Life), formulary tier, and whether prior authorization is approved. As of 2026, Mounjaro is classified as a Tier 3 or Tier 4 medication on Tricare’s formulary, meaning it is a non-preferred brand-name drug with higher copayments.

For Tricare Prime beneficiaries, the cost structure is as follows:

• Active-duty service members: $0 copay (Mounjaro is fully covered if medically necessary and prior authorized).
• Retirees and dependents: $29–$60 per month for a 30-day supply, depending on the dosage (e.g., 5 mg, 10 mg, or 15 mg).
• Catastrophic cap: Once annual out-of-pocket costs reach $3,000 (for retirees) or $1,000 (for active-duty families), copays are waived for the remainder of the year.

For Tricare Select beneficiaries, costs are higher:

• Retirees and dependents: 25% coinsurance of the negotiated retail price, which can range from $250–$400 per month for Mounjaro.
• Non-network providers: Patients may face higher out-of-pocket costs if they obtain Mounjaro from a non-Tricare network pharmacy.

Without Tricare coverage, the retail price of Mounjaro averages $1,000–$1,300 per month. Patients should verify their specific plan details and use Tricare’s Express Scripts pharmacy network to minimize costs.

Mounjaro Prior Authorization for Tricare

Prior authorization (PA) is mandatory for Tricare to cover Mounjaro, whether for diabetes or weight loss. The PA process ensures that Mounjaro is medically necessary and that alternative, less expensive treatments have been exhausted. Providers must submit a detailed request to Tricare’s pharmacy benefits manager, Express Scripts, including the following documentation:

1. Patient’s medical history: Confirmed diagnosis of type 2 diabetes (HbA1c ≥ 7.0%) or obesity (BMI ≥ 30 with comorbidities).
2. Failed alternative therapies: Evidence of inadequate response to or intolerance of at least two other diabetes medications (e.g., metformin, SGLT2 inhibitors) or weight-loss interventions (e.g., diet, exercise, orlistat).
3. Clinical justification: Explanation of why Mounjaro is the most appropriate treatment, supported by peer-reviewed studies or guidelines (e.g., ADA, Obesity Medicine Association).
4. Dosage and duration: Proposed treatment plan, including starting dose (e.g., 2.5 mg) and titration schedule.

The PA review process typically takes 5–10 business days. If approved, Tricare will cover Mounjaro for a specified duration (e.g., 6–12 months), after which providers must submit a renewal request. Denials can occur if documentation is incomplete or if the patient does not meet Tricare’s criteria. In such cases, patients may appeal the decision (see next section).

How to Get Tricare to Cover Mounjaro

Securing Tricare coverage for Mounjaro requires a proactive, evidence-based approach. Follow these steps to improve the likelihood of approval:

1. Consult a Tricare-authorized provider: Only providers within the Tricare network can submit prior authorization requests. Military treatment facilities (MTFs) or civilian providers with Tricare contracts are ideal.
2. Gather medical records: Ensure your provider has documentation of:
   • Failed alternative treatments (e.g., metformin for diabetes, lifestyle interventions for weight loss).
   • Relevant lab results (e.g., HbA1c, lipid panels, BMI measurements).
   • Comorbidities that justify Mounjaro’s use (e.g., hypertension, sleep apnea).
3. Submit a detailed prior authorization request: Your provider should emphasize Mounjaro’s clinical benefits, such as superior HbA1c reduction or weight loss compared to alternatives like Ozempic or Wegovy.
4. Follow up with Express Scripts: After submission, check the status of your PA request through the Express Scripts portal or by calling their customer service line.
5. Consider a peer-to-peer review: If initially denied, your provider can request a discussion with a Tricare medical director to present additional evidence.

For weight loss, emphasize Mounjaro’s role in improving obesity-related comorbidities rather than cosmetic benefits. Including a letter of medical necessity from a specialist (e.g., endocrinologist, obesity medicine physician) can strengthen the case.

What to Do If Tricare Denies Mounjaro

If Tricare denies coverage for Mounjaro, patients have multiple avenues for appeal. The denial letter will outline the reason (e.g., lack of medical necessity, incomplete documentation) and the steps to appeal. Here’s how to proceed:

1. Request a reconsideration: The first step is to submit a reconsideration request within 90 days of the denial. Your provider should:
   • Address the specific reason for denial (e.g., provide missing lab results or additional evidence of failed alternatives).
   • Include new clinical data or studies supporting Mounjaro’s use for your condition.
2. File a formal appeal: If reconsideration is denied, you can escalate to a formal appeal with Tricare’s appeals office. This involves:
   • Submitting a written appeal letter, including your medical records, provider’s notes, and any relevant guidelines (e.g., ADA standards).
   • Requesting an independent review by a third-party medical expert if the appeal is denied at the regional level.
3. Seek assistance from a patient advocate: Tricare beneficiaries can contact the Tricare Regional Office or a patient advocate at their MTF for guidance. Advocates can help navigate the appeals process and ensure all documentation is submitted correctly.
4. Explore external appeals: If all Tricare appeals are exhausted, patients can request an external review through their state’s insurance commissioner or the Department of Defense’s Office of Hearings and Appeals.

While appeals can be time-consuming, persistence is key. Many denials are overturned with additional evidence or provider advocacy.

Tricare Alternatives If Mounjaro Is Not Covered

If Tricare denies coverage for Mounjaro or the out-of-pocket costs are prohibitive, patients can explore alternative medications and programs covered by Tricare:

1. For diabetes:

   • GLP-1 agonists: Tricare covers semaglutide (Ozempic, Rybelsus) and dulaglutide (Trulicity) as preferred alternatives to Mounjaro. These medications are similarly effective for glycemic control and may have lower copays.
   • SGLT2 inhibitors: Empagliflozin (Jardiance) and dapagliflozin (Farxiga) are covered and may be used in combination with metformin.
   • Insulin: For patients with advanced diabetes, Tricare covers various insulin formulations (e.g., Lantus, Humalog) with minimal copays.

2. For weight loss:

   • Tricare’s MOVE! program: A free, evidence-based weight-management program for beneficiaries, including nutrition counseling and physical activity plans.
   • Phentermine: A short-term appetite suppressant covered by Tricare for patients with a BMI ≥ 30.
   • Orlistat (Alli, Xenical): A lipase inhibitor covered for chronic weight management in patients with obesity.
   • Bariatric surgery: Tricare covers weight-loss surgery (e.g., gastric bypass, sleeve gastrectomy) for patients with a BMI ≥ 40 or BMI ≥ 35 with comorbidities.

3. Manufacturer savings programs:

   • Mounjaro Savings Card: Eli Lilly offers a savings program that reduces the cost of Mounjaro to $25 per month for eligible patients with commercial insurance. While Tricare beneficiaries do not qualify, those with secondary private insurance may benefit.
   • Patient assistance programs: Lilly’s Lilly Cares Foundation provides free Mounjaro to uninsured or underinsured patients who meet income criteria.

Patients should discuss these alternatives with their provider to determine the best course of action.

Frequently Asked Questions

Does Tricare cover Mounjaro for weight loss?

Tricare does not routinely cover Mounjaro for weight loss alone, as it is not FDA-approved solely for obesity treatment under Tricare’s current policies. However, coverage may be approved for patients with a BMI ≥ 40 or those with obesity-related comorbidities (e.g., type 2 diabetes, sleep apnea) who have failed other weight-loss interventions. Prior authorization is required, and approval is granted on a case-by-case basis.

How much is the Mounjaro copay with Tricare?

The Mounjaro copay with Tricare varies by plan. For Tricare Prime beneficiaries, copays range from $29–$60 per month for retirees and dependents, while active-duty service members pay $0 if prior authorization is approved. Tricare Select beneficiaries pay 25% coinsurance of the negotiated retail price, which can range from $250–$400 per month. Costs may be lower if Mounjaro is obtained through Tricare’s mail-order pharmacy.

Can I appeal if Tricare denies Mounjaro?

Yes, patients can appeal a Tricare denial for Mounjaro through a multi-step process. Start with a reconsideration request, where your provider submits additional evidence to address the denial reason. If denied